Advertisement
Loading...

UCB SA

UCBJFPNK
Healthcare
Biotechnology
$270.35
$-11.90(-4.22%)
U.S. Market opens in 7h 7m

UCB SA (UCBJF) Stock Overview

Explore UCB SA’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap51.5B
P/E Ratio29.70
EPS (TTM)$9.23
ROE0.15%
Fundamental Analysis

AI Price Forecasts

1 Month$259.95
3 Months$310.40
1 Year Target$253.24

UCBJF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of UCB SA (UCBJF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 39.48, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $253.24.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 29.70 and a market capitalization of 51.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-4.22%
5-Day Change
-6.49%
1-Month Change
-3.43%
3-Month Change
-20.07%
6-Month Change
5.46%
Year-to-Date (YTD) Change
-7.91%
1-Year Change
53.83%
3-Year Change
184.58%
5-Year Change
181.29%
All-Time (Max) Change
555.39%

Contact Information

32 2 559 99 99
Allée de la Recherche, 60, Brussels, NaN, 1070

Company Facts

9,052 Employees
IPO DateAug 26, 2008
CountryBE
Actively Trading

Frequently Asked Questions